9 research outputs found
Levels of pepsinogens, gastrin, and percentage of subjects seropositive for <i>H. pylori</i>, and CagA according to the topography of moderate/marked gastritis and atrophy.
<p>SD: Standard deviation, IQR: interquartile range, PGI: pepsinogen I, PGII: pepsinogen II, CagA: cytotoxin-associated gene A, PPI (proton pump inhibitor).</p><p>*<i>H. pylori</i> status was determined according to the results of histology examination, ELISA IgA/IgG, and Western blot.</p
Screening characteristics of PGI and PGI/PGII ratio for diagnosis of fundic atrophy and nonatrophic pangastritis.
<p>CI: confidence interval, AUC: area under curve, PPV: positive predictive value, NPV: negative predictive value, PGI: pepsinogen I, PGII: pepsinogen II, G-17: gastrin-17.</p
Proportion of PPI use, <i>H. pylori</i> infection and fundic atrophy among categories generated by G-17 cutoff values.
<p>G-17: gastrin-17, PPI: proton pump inhibitor, IQR: interquartile range.</p><p>*Fundic atrophy was defined by histology gold standard.</p
AUCs for discrimination of fundic atrophy (dark bar), and nonatrophic pangastritis (dotted bar represents the study population after exclusion of fundic atrophy from reference group, diagonal lined bar represents whole study population).
<p>AUC: Area under curve, PGI: pepsinogen I, PGII. pepsinogen II, PGI/PGII ratio: pepsinogen I/pepsinogen II ratio, G-17: gastrin-17.</p
Nass use and risk of ESCC in cases and controls in the two phases of the Golestan Case-Control Study of ESCC in Golestan Province, Iran.
*<p>Adjusted for cigarette smoking, opium and hookah consumption, ethnicity, education and place of residence.</p>**<p>Median of control group in each set.</p>***<p>Cumulative = duration×amount.</p
Determinants of opium use in hospital and neighborhood controls in the two phases of the Golestan Case-Control Study in Golestan Province, Iran.
*<p>Model includes all the variables in the table except source of controls;</p>**<p>model includes all the variables in the table.</p><p>OR: odds ratio; CI: Confidence interval;</p>†<p>p<0.05;</p>‡<p>p<0.01;</p>¶<p>p<0.001.</p
Opium use and risk of ESCC in cases and controls in the two phases of the Golestan Case-Control Study of ESCC in Golestan Province, Iran.
*<p>Adjusted for cigarette smoking, nass, hookah, ethnicity, education and place of residence.</p>**<p>Median of control group in each study.</p
Hookah use in cases and controls of the two phases of the Golestan Case-Control Study of ESCC in Golestan Province, Iran.
*<p>Adjusted for cigarette smoking, opium, nass, ethnicity, education and place of residence.</p>**<p>Median of control group in each study.</p>***<p>Cumulative = duration×amount.</p
Cigarette use and risk of ESCC in cases and controls in the two phases of the Golestan Case-Control Study of ESCC in Golestan Province, Iran.
*<p>Adjusted for opium, nass, hookah, ethnicity, education and place of residence.</p>**<p>Median of control group in each set.</p>***<p>Cumulative = duration×amount.</p